ESPERION THERAPEUTICS INC/MI
S-1/A, EX-27.2, 2000-07-10
PHARMACEUTICAL PREPARATIONS
Previous: ESPERION THERAPEUTICS INC/MI, S-1/A, EX-27.1, 2000-07-10
Next: MACK CALI REALTY L P, 8-K, 2000-07-10



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999             DEC-31-2000
<PERIOD-START>                             JAN-01-1999             JAN-01-2000
<PERIOD-END>                               MAR-31-1999             MAR-31-2000
<CASH>                                               0              27,698,068
<SECURITIES>                                         0                       0
<RECEIVABLES>                                        0                       0
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                     0              28,107,216
<PP&E>                                               0               2,551,118
<DEPRECIATION>                                       0                 625,623
<TOTAL-ASSETS>                                       0              30,488,711
<CURRENT-LIABILITIES>                                0               3,260,111
<BONDS>                                              0               2,123,469
                                0                       0
                                          0                 218,892
<COMMON>                                             0                   2,202
<OTHER-SE>                                           0              45,960,126
<TOTAL-LIABILITY-AND-EQUITY>                         0              30,488,711
<SALES>                                              0                       0
<TOTAL-REVENUES>                                     0                       0
<CGS>                                                0                       0
<TOTAL-COSTS>                                        0                       0
<OTHER-EXPENSES>                             1,584,740               5,069,072
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                             135,595                 350,710
<INCOME-PRETAX>                            (1,450,030)             (4,693,152)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                        (1,450,030)             (4,693,152)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0            (22,869,760)
<CHANGES>                                            0                       0
<NET-INCOME>                               (1,450,030)            (27,562,912)
<EPS-BASIC>                                     (0.85)                 (13.91)
<EPS-DILUTED>                                   (0.85)                 (13.91)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission